rdf:type |
|
lifeskim:mentions |
umls-concept:C0017262,
umls-concept:C0018270,
umls-concept:C0031715,
umls-concept:C0109317,
umls-concept:C0162508,
umls-concept:C0185117,
umls-concept:C0221920,
umls-concept:C0752312,
umls-concept:C1150579,
umls-concept:C1333340,
umls-concept:C1366882,
umls-concept:C1370600,
umls-concept:C1412615,
umls-concept:C1514873,
umls-concept:C1546857,
umls-concept:C1556066,
umls-concept:C1619636,
umls-concept:C1704259,
umls-concept:C1705767,
umls-concept:C1705791,
umls-concept:C1705987,
umls-concept:C2911684
|
pubmed:issue |
52
|
pubmed:dateCreated |
2002-12-23
|
pubmed:abstractText |
Epidermal growth factor induction of c-jun expression requires ATF1 and MEF2 sites in the c-jun promoter. We find that activation of the c-jun promoter through the ATF1 site requires phosphorylation of ATF1 at serine 63. A serine 63 to alanine mutation of ATF1 acts to block epidermal growth factor (EGF) induction of a transfected c-jun gene. ATF1 can be phosphorylated by mitogen- and stress-activated protein kinase 1 (MSK1), which is activated by EGF and ERK1/2. Kinase-dead MSK1 mutants blocked EGF induction of a transfected c-jun gene suggesting that MSK1 or a similar family member is required for induced c-jun expression. Use of the MEK1 inhibitor U0126 and dominant negative MEK1 further showed that MSK1 activation and c-jun induction require the ERK pathway. In contrast, a JNK inhibitor blocked EGF induction of c-jun expression but not ATF1 phosphorylation. These results show that the two MAPK pathways, ERK and JNK, are required for EGF-induced c-jun expression and that the ERK pathway acts through downstream phosphorylation of ATF1.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Activating Transcription Factor 1,
http://linkedlifedata.com/resource/pubmed/chemical/Atf1 protein, mouse,
http://linkedlifedata.com/resource/pubmed/chemical/DNA-Binding Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Epidermal Growth Factor,
http://linkedlifedata.com/resource/pubmed/chemical/Mitogen-Activated Protein Kinases,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Ribosomal Protein S6 Kinases, 90-kDa,
http://linkedlifedata.com/resource/pubmed/chemical/Transcription Factors,
http://linkedlifedata.com/resource/pubmed/chemical/mitogen and stress-activated...
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0021-9258
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
27
|
pubmed:volume |
277
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
50550-6
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:12414794-Activating Transcription Factor 1,
pubmed-meshheading:12414794-Animals,
pubmed-meshheading:12414794-DNA-Binding Proteins,
pubmed-meshheading:12414794-Enzyme Inhibitors,
pubmed-meshheading:12414794-Epidermal Growth Factor,
pubmed-meshheading:12414794-Gene Expression Regulation,
pubmed-meshheading:12414794-Genes, jun,
pubmed-meshheading:12414794-HeLa Cells,
pubmed-meshheading:12414794-Humans,
pubmed-meshheading:12414794-MAP Kinase Signaling System,
pubmed-meshheading:12414794-Mice,
pubmed-meshheading:12414794-Mitogen-Activated Protein Kinases,
pubmed-meshheading:12414794-Phosphorylation,
pubmed-meshheading:12414794-Promoter Regions, Genetic,
pubmed-meshheading:12414794-Recombinant Proteins,
pubmed-meshheading:12414794-Ribosomal Protein S6 Kinases, 90-kDa,
pubmed-meshheading:12414794-Transcription Factors,
pubmed-meshheading:12414794-Transfection
|
pubmed:year |
2002
|
pubmed:articleTitle |
ATF1 phosphorylation by the ERK MAPK pathway is required for epidermal growth factor-induced c-jun expression.
|
pubmed:affiliation |
Department of Biological Sciences, Columbia University, New York, New York 10027, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|